Back to REGN
Bellevue Group AG REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
8
Latest value
$211.9M
Q3 2026
Peak value
$214.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $1.8M |
| Q4 2025 | $8.9M |
| Q1 2026 | $1.2M |
| Q1 2026 | $214.1M |
| Q2 2026 | $181K |
| Q2 2026 | $97.9M |
| Q3 2026 | $123K |
| Q3 2026 | $211.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $211.9M | 279.4K | — | — |
| Q3 2026 | $123K | 162 | — | — |
| Q2 2026 | $97.9M | 157.0K | — | — |
| Q2 2026 | $181K | 291 | — | — |
| Q1 2026 | $214.1M | 277.1K | — | — |
| Q1 2026 | $1.2M | 1.5K | — | — |
| Q4 2025 | $8.9M | 11.6K | — | — |
| Q4 2025 | $1.8M | 2.4K | — | — |